Cargando…
Selenium Protects Mouse Hypothalamic Cells from Glucocorticoid-Induced Endoplasmic Reticulum Stress Vulnerability and Insulin Signaling Impairment
The use of glucocorticoid medications is known to cause metabolic side effects such as overeating, excess weight gain, and insulin resistance. The hypothalamus, a central regulator of feeding behavior and energy expenditure, is highly responsive to glucocorticoids, and it has been proposed that it p...
Autores principales: | An, Katlyn J., Hanato, Ashley N., Hui, Katherine W., Pitts, Matthew W., Seale, Lucia A., Nicholson, Jessica L., Toh, Pamela, Kim, Jun Kyoung, Berry, Marla J., Torres, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952756/ https://www.ncbi.nlm.nih.gov/pubmed/36830084 http://dx.doi.org/10.3390/antiox12020526 |
Ejemplares similares
-
Prolonged maternal exposure to glucocorticoids alters selenoprotein expression in the developing brain
por: Toh, Pamela, et al.
Publicado: (2023) -
Female Mice with Selenocysteine tRNA Deletion in Agrp Neurons Maintain Leptin Sensitivity and Resist Weight Gain While on a High-Fat Diet
por: Torres, Daniel J., et al.
Publicado: (2021) -
Selenium in Bodily Homeostasis: Hypothalamus, Hormones, and Highways of Communication
por: Toh, Pamela, et al.
Publicado: (2022) -
Selenium and Metabolic Disorders: An Emphasis on Type 2 Diabetes Risk
por: Ogawa-Wong, Ashley N., et al.
Publicado: (2016) -
Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers
por: Shimada, Briana K., et al.
Publicado: (2022)